Kewaunee Scientific Reports 46.9% Increase in Q1 Sales and 61.3% Rise in Pre-Tax Earnings; EPS Climbs to $1.04
Reuters
Sep 11
Kewaunee Scientific Reports 46.9% Increase in Q1 Sales and 61.3% Rise in Pre-Tax Earnings; EPS Climbs to $1.04
Kewaunee Scientific Corporation announced its financial results for the first quarter of fiscal year 2026, which ended on July 31, 2025. The company reported sales of $71.1 million, marking a 46.9% increase compared to $48.4 million from the previous year's first quarter. Pre-tax earnings for the quarter rose by 61.3% to $3.92 million, up from $2.43 million in the prior year quarter. Net earnings were $3.1 million, an increase from $2.2 million in the same period last year. Diluted earnings per share were reported at $1.04, compared to $0.74 in the previous year quarter. Kewaunee's order backlog was reported to be $205.0 million as of July 31, 2025. Despite solid performance in the first quarter, Kewaunee anticipates uneven quarterly performance for the remainder of fiscal year 2026 due to volatility in project delivery timelines and challenging market conditions. The company is committed to strategic investments aimed at fostering both organic and inorganic growth, which are expected to impact near-term earnings growth but position the company for rapid and sustained growth in the future.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Kewaunee Scientific Corporation published the original content used to generate this news brief via PR Newswire (Ref. ID: CL70866) on September 10, 2025, and is solely responsible for the information contained therein.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.